SUPER BUGS Act of 2026
- Sponsor
- Rep. Levin, Mike [D-CA-49]
- Committees
- Foreign Affairs Committee (primary)
- Last action
- Mar 9, 2026
Bottom line
This bill seeks to establish a coordinated international strategy to accelerate the development and deployment of medical countermeasures against future pandemics and antimicrobial resistance threats, enhancing global health security.
What it actually does
This bill mandates the Secretary of State, in consultation with the Secretary of Health and Human Services and other agencies, to formulate an international strategy within 18 months. The strategy's purpose is to secure support from foreign countries and multilateral organizations to facilitate the development and commercialization of qualified pandemic or epidemic products, particularly those addressing antimicrobial-resistant pathogens. It outlines specific requirements for the strategy's content, focusing on equitable contributions, global priorities, strengthening partner country public health capabilities, and harmonizing international efforts.
Proponents argue
Supporters argue that emerging infectious diseases, including antimicrobial-resistant pathogens, pose a significant threat to United States national security, economic stability, and public health. They contend that strengthening international collaboration to develop and deploy pandemic products is essential to preventing and containing these threats before they reach U.S. borders, directly contributing to homeland security and global resilience.
Opponents contend
Critics might argue that mandating such a broad international strategy could overextend the State Department's resources and expertise into public health diplomacy, potentially diverting focus from other critical foreign policy objectives. Some may also express concerns about the practical challenges of ensuring 'equitable contributions' and harmonizing efforts across diverse international partners, or that it could lead to the U.S. bearing a disproportionate share of the financial and logistical burden.
The bill is concise and clearly written, making it accessible for a quick and thorough understanding by an informed reader.
Section 4(a)(1)
Requirement to Formulate an International Strategy
This provision requires the Secretary of State, in collaboration with the Secretary of Health and Human Services and other relevant agencies, to formulate an international strategy within 18 months of the bill's enactment. The strategy's core objective is to secure support from foreign countries, multilateral organizations, and other entities to facilitate the development and commercialization of qualified pandemic or epidemic products, specifically including those targeting antimicrobial-resistant pathogens with pandemic potential or identified as priority pathogens.
Supporters argue
Supporters argue this mandate is essential for proactive global health security, ensuring the U.S. leads in coordinating international efforts to combat future pandemics and antimicrobial resistance, thereby protecting American citizens and interests.
Critics contend
Critics might argue that such a broad mandate could be difficult to implement effectively given the complexities of international diplomacy and varying national interests, potentially leading to a strategy that lacks concrete actionable steps or sufficient buy-in from all partners.
Tradeoffs
The tension lies between the clear need for global coordination on health threats and the practical challenges of achieving genuine, equitable international cooperation and resource allocation among diverse nations.
Section 4(a)(2)
Specific Requirements for Strategy Content
This section details the mandatory components of the international strategy. It must include processes for entering arrangements, promoting equitable contributions, focusing on global priorities while allowing for national emphasis, strengthening partner country public health capabilities, harmonizing efforts, allocating responsibilities for product development, ensuring stewardship of products, identifying priority actions for funding, considering private sector contracts and alternative payment models, and streamlining regulatory approval processes. The strategy must also be synchronized with existing U.S. pandemic preparedness priorities.
Section 4(b)
Seeking International Arrangements for Implementation
This subsection directs the Secretary of State, in consultation with HHS and other relevant agencies, to actively seek and enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities. The purpose of these arrangements is to implement the international strategy developed under subsection (a), moving the initiative from a planning phase to active diplomatic engagement and formalizing international cooperation.